Rheum360: Systemic Lupus Erythematosus – Challenging Cases

0.75 CME
45 MINS
$0 FEE
SAVE
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Rheum360: Systemic Lupus Erythematosus – Challenging Cases

Overview

Provider Statement

This continuing medical education activity is provided by Vindico Medical Education


Support Statement

This educational activity is supported by an educational grant from GlaxoSmithKline.


Activity Description

Systemic lupus erythematosus (SLE) is an autoimmune disease that affects both children and adults, occurring most commonly in women of childbearing age. Individuals diagnosed with SLE can experience widespread inflammation and tissue damage affecting multiple organ systems, including the skin, joints, kidneys, and brain. Careful patient workup, routine monitoring, and timely treatment adjustments are critical to prevent organ damage and support improved patient outcomes. Ongoing education is essential to keep clinicians apprised of the latest evidence-based treatment approaches. In this issue, faculty present four unique cases of SLE to illustrate the heterogeneity of disease and important considerations for diagnosis and treatment. Experts will review current evidence, treatment guidelines, and offer key guidance on strategies for patient monitoring and counselling to ensure optimal disease control.


Target Audience

The intended audience for this activity is rheumatologists and other health care professionals involved in the management of patients with SLE.


Learning Objectives

Upon successful completion of this educational activity, participants should be better able to:

  • Identify patients with SLE and organ involvement in a timely manner to ensure proper management.
  • Apply the latest evidence and guidelines to the treatment of adults and adolescents with SLE.
  • Assess patients being treated for SLE for disease activity and manage accordingly.
  • Review strategies for patient monitoring and counselling to ensure disease control, even in patients who have achieved clinical remission.

Chief Medical Editor

Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Cleveland Clinic
Cleveland, OH


Faculty

Emily Littlejohn, DO
Clinical Assistant Professor of Medicine
Co-director, Lupus Clinic
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
Cleveland, OH

Daniel J. Wallace, MD, FACP, MACR
Associate Director, Rheumatology Fellowship Program
Board of Governors, Cedars- Sinai Medical Center
Professor of Medicine, Cedars-Sinai Medical Center
David Geffen School of Medicine Center at UCLA
Los Angeles, CA 


Reviewer

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP


Accreditation

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

This enduring material is approved for 1 year from the date of original release, July 15, 2021, to July 14, 2022.


How to Participate in This Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 6 of the 8 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.


Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of accredited content. Individuals have a relevant financial relationship if they have a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control.

Chief Medical Editor and Faculty report the following relationship(s)

Leonard H. Calabrese, DO
Consulting Fee: AbbVie, Bristol Myers Squibb, Crescendo, Genentech, Gilead, GlaxoSmithKline, Horizon, Janssen, Lilly, Pfizer, Regeneron, Sanofi-Genzyme, UCB
Speakers Bureau: AbbVie, Bristol Myers Squibb, Celgene, Genentech, Horizon, Janssen, Lilly, Regeneron, Sanofi, UCB

Emily Littlejohn, DO
Speakers Bureau: Aurinia

Daniel J. Wallace, MD, FACP, MACR
Consulting Fee: Aurinia, EMD Serono, GlaxoSmithKline, Lilly, Pfizer

Reviewer reports the following relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose. 

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.


Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.


Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2021 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.


CME Questions?

Contact us at cme@vindicoCME.com